Novanta (NOVT) Updates FY18 Earnings Guidance

Novanta (NASDAQ:NOVT) updated its FY18 earnings guidance on Tuesday. The company provided earnings per share guidance of $2.07-2.12 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.00. The company issued revenue guidance of $610-614 million, compared to the consensus revenue estimate of $605.10 million.

A number of research analysts have recently issued reports on the company. BidaskClub raised Novanta from a sell rating to a hold rating in a research note on Wednesday. ValuEngine raised Novanta from a hold rating to a buy rating in a research note on Wednesday, October 31st. Finally, Zacks Investment Research cut Novanta from a buy rating to a hold rating in a research note on Wednesday, October 10th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The stock currently has an average rating of Hold and a consensus target price of $64.00.

Shares of NASDAQ:NOVT traded up $1.84 on Wednesday, reaching $75.84. 10,992 shares of the company traded hands, compared to its average volume of 216,007. Novanta has a 52 week low of $43.65 and a 52 week high of $78.85. The stock has a market capitalization of $2.15 billion, a P/E ratio of 47.50 and a beta of 1.72. The company has a current ratio of 3.18, a quick ratio of 2.14 and a debt-to-equity ratio of 0.61.

Novanta (NASDAQ:NOVT) last announced its quarterly earnings data on Tuesday, November 6th. The technology company reported $0.61 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.52 by $0.09. The firm had revenue of $160.79 million for the quarter, compared to analysts’ expectations of $154.43 million. Novanta had a return on equity of 19.99% and a net margin of 5.14%. The company’s revenue for the quarter was up 9.9% compared to the same quarter last year. During the same period last year, the firm earned $0.45 earnings per share. As a group, research analysts predict that Novanta will post 2 EPS for the current year.

In related news, CEO Matthijs Glastra sold 20,000 shares of the firm’s stock in a transaction dated Tuesday, November 6th. The stock was sold at an average price of $74.00, for a total value of $1,480,000.00. Following the sale, the chief executive officer now directly owns 71,107 shares of the company’s stock, valued at $5,261,918. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Peter L. Chang sold 3,680 shares of the firm’s stock in a transaction dated Friday, August 17th. The stock was sold at an average price of $70.63, for a total value of $259,918.40. Following the completion of the sale, the vice president now directly owns 36,132 shares in the company, valued at $2,552,003.16. The disclosure for this sale can be found here. Insiders sold 37,167 shares of company stock worth $2,723,121 over the last three months. 6.70% of the stock is owned by insiders.

COPYRIGHT VIOLATION WARNING: This report was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The original version of this report can be viewed at https://www.dispatchtribunal.com/2018/11/07/novanta-novt-updates-fy18-earnings-guidance.html.

About Novanta

Novanta Inc, together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products for photonics-based applications, such as industrial material processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.

Further Reading: Initial Public Offering (IPO)

Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply